Jordi Remon/X
Dec 24, 2024, 00:18
Jordi Remon: 2024 – Fortunately it is difficult to merge all treatments for NSCLC
Jordi Remon, Thoracic oncologist at CIOCC Barcelona, shared a post on X:
“2024: Fortunately it is difficult to merge all treatments for Non-Small Cell Lung Cancer (NSCLC) in 1 slide.
Hwv, still pending:
- Avoid me too approvals if prices not.
- Consol TKI for all and for lifetime?
- Genotyping access and drug access.
- Academic trials of de-escalating periop vs neoadjuvant.”
More posts featuring Jordi Remon.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 21, 2025, 10:23
Aug 21, 2025, 10:08
Aug 21, 2025, 09:30
Aug 21, 2025, 08:17
Aug 21, 2025, 06:29
Aug 21, 2025, 00:00
Aug 20, 2025, 23:11